Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Insight Molecular Diagnostics' Tax Provisions history spans 2 years, with the latest figure at -$97000.0 for Q4 2021.

  • For Q4 2021, Tax Provisions fell 161.01% year-over-year to -$97000.0; the TTM value through Sep 2024 reached -$97000.0, changed N/A, while the annual FY2022 figure was -$1.2 million, 87.04% up from the prior year.
  • Tax Provisions for Q4 2021 was -$97000.0 at Insight Molecular Diagnostics, down from $1.8 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.8 million in Q2 2021 and bottomed at -$7.6 million in Q1 2021.